The Government continues to work with the sector on opportunities to deploy additional shore power and other infrastructure. The Government is considering shore power within the wider context of net zero ports and will launch a call for evidence in due course. This will gather further information on future electricity grid capacity needs to support additional infrastructure, including shore power.<\/p>
<\/p>
On 11 September, the government announced £29.5m of R&D funding for shore power projects at the Port of Aberdeen, Atlantic and Peninsula\u2019s Falmouth Port and Portsmouth International Port under the Zero Emission Vessels and Infrastructure competition. These projects will help to reduce emissions at these locations in the short term and will also provide valuable evidence over the multi-year demonstration period to inform future policy and regulation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4580", "label" : {"_value" : "Biography information for Baroness Vere of Norbiton"} } , "answeringMemberPrinted" : {"_value" : "Baroness Vere of Norbiton"} , "dateOfAnswer" : {"_value" : "2023-09-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-27T10:15:05.767Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2023-09-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Energy: Ports"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of the current shore power capacity at ports in the UK; and what will be the percentage expansion of capacity required by 2050 to achieve their net zero targets.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4230", "label" : {"_value" : "Biography information for Baroness Randerson"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Randerson"} ], "uin" : "HL10269"} , {"_about" : "http://data.parliament.uk/resources/1251614", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1251614/answer", "answerText" : {"_value" : "
At present, only one ivermectin-containing product is approved in the United Kingdom (Soolantra 10 mg/g cream) but this is not indicated in the treatment of scabies in tablet form. The Medicines and Healthcare products Regulatory Agency (MHRA) are aware that Stromectol 3mg tablets, containing ivermectin, are approved in France and are used for the treatment of scabies but this is not licensed in the UK.<\/p>
In order for the MHRA to approve a medicine for use in the UK, a manufacturer has to apply to obtain a marketing authorisation. The MHRA makes its decision to approve a licence for a product based on safety, quality and efficacy criteria, irrespective of the cost. Thus far, the MHRA has not received any application for tablets of ivermectin.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-11-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-11-24T16:37:23.93Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-11-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ivermectin: Licensing"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have, if any, to license Ivermectin in tablet form for older children and adults, in line with World Health Organisation guidelines for essential drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"} ], "uin" : "HL10269"} , {"_about" : "http://data.parliament.uk/resources/971908", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/971908/answer", "answerText" : {"_value" : "
The Medical Training Initiative is a Government Authorised Exchange scheme, a sub-category of our Tier 5 (Temporary Worker) route. None of our Tier 5 (Temporary Worker) sub-categories, including Government Authorised Exchange sub-category, impose a cap. The numbers of participants on each scheme, including the Medical Training Initiative, are however monitored in line with the scheme proposal agreed with the Home Office.<\/p>
The Home Office is in regular contact with all government departments regarding the operation of the UK\u2019s immigration system.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4311", "label" : {"_value" : "Biography information for Baroness Williams of Trafford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Williams of Trafford"} , "dateOfAnswer" : {"_value" : "2018-09-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL10268"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-09-17T12:54:20.403Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Visas: Doctors"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what cross-governmental discussions have taken place with regard to making more Tier 5 visas available for the Medical Training Initiative.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2539", "label" : {"_value" : "Biography information for Baroness Northover"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Northover"} ], "uin" : "HL10269"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }